Review in Antibodies (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Aya JalilHealth Sciences Research Center, Higher School of Biomedical Engineering, College of Health Sciences, International University of Rabat, Technopolis Parc, Rocade of Rabat-Salé, Sala-Al Jadida 11100, Morocco.ORCID 0009-0002-1046-8259
Nadia TouilCenter of Virology, Infectious and Tropical Diseases, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy of Rabat, Biomedical Research and Epidemiology Unit (URBE), Rabat 10100, Morocco.ORCID 0000-0003-4183-7758
Omar NyabiCenter for Applied Molecular Technologies (CTMA), Institute of Clinical and Experimental Research, Université Catholique de Louvain, 1200 Brussels, Belgium.ORCID 0000-0003-0479-4103
Elmostafa El FahimeMohammed VI Center of Research and Innovation, Mohammed VI University of Sciences and Health, Rabat 10100, Morocco.ORCID 0000-0001-7812-0641
Sara BenlhachemiMohammed VI Center of Research and Innovation, Mohammed VI University of Sciences and Health, Rabat 10100, Morocco.ORCID 0000-0002-3729-8934
Jean-Luc GalaCenter for Applied Molecular Technologies (CTMA), Institute of Clinical and Experimental Research, Université Catholique de Louvain, 1200 Brussels, Belgium.ORCID 0000-0002-7749-573X
Khalid EnnibiCenter of Virology, Infectious and Tropical Diseases, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy of Rabat, Biomedical Research and Epidemiology Unit (URBE), Rabat 10100, Morocco.
Karim BakkouriMohammed VI Center of Research and Innovation, Mohammed VI University of Sciences and Health, Rabat 10100, Morocco.
Abdelaziz BenjouadHealth Sciences Research Center, Higher School of Biomedical Engineering, College of Health Sciences, International University of Rabat, Technopolis Parc, Rocade of Rabat-Salé, Sala-Al Jadida 11100, Morocco.ORCID 0000-0002-0459-4219
Lamiae BelayachiHealth Sciences Research Center, Higher School of Biomedical Engineering, College of Health Sciences, International University of Rabat, Technopolis Parc, Rocade of Rabat-Salé, Sala-Al Jadida 11100, Morocco.ORCID 0009-0002-0389-5260
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Analytical Performance of Nanobody-Based Immunoassay and Immunosensing Platforms for Bacteria and Toxin Detection: A Systematic Review. · full record | Socratic